Relapsed/Refractory B-cell Lymphoma
11 clinical trials · Condition
◉ Watch Relapsed/Refractory B-cell Lymphoma
| Record | Firm | Date |
|---|---|---|
| A Clinical Study Evaluating the Safety and Efficacy of BinD19 Treatment in R/R ALL and Lymphoma Subjects (NCT03156101) | Shenzhen BinDeBio Ltd. | 2017-03-02 |
| A Phase IB Study Of The BTKi CC-292 Combined With Lenalidomide In Adults Patients With Relapsed/Refractory B-Cell Lymphoma (NCT01766583) | The Lymphoma Academic Research Organisation | 2013-02-01 |
Track Relapsed/Refractory B-cell Lymphoma automatically
Every clearance here is in the API, with alerts when new ones post.